Publications by authors named "Jennifer Inghrim"

Claim this Profile
S
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine Inhibitors.
Amy C Hart, Gretchen M Schroeder, Honghe Wan, James Grebinski, Jennifer Inghrim

ACS Med Chem Lett· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms.
Honghe Wan, Gretchen M Schroeder, Amy C Hart, Jennifer Inghrim, James Grebinski

ACS Med Chem Lett· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrrolo[1,2-f]triazines as JAK2 inhibitors: achieving potency and selectivity for JAK2 over JAK3.
Lalgudi S Harikrishnan, Muthoni G Kamau, Honghe Wan, Jennifer A Inghrim, Kurt Zimmermann

Bioorg Med Chem Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spirodiepoxides: synthesis of epoxomicinoids.
Yue Zhang, Joseph R Cusick, Partha Ghosh, Ning Shangguan, Sreenivas Katukojvala, Jennifer Inghrim

J Org Chem· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silyl-substituted spirodiepoxides: stereoselective formation and regioselective opening.
Partha Ghosh, Joseph R Cusick, Jennifer Inghrim, Lawrence J Williams

Org Lett· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
Nicole T Hatzenbuhler, Deborah A Evrard, Boyd L Harrison, Donna Huryn, Jennifer Inghrim

J Med Chem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis